Hybrid fertility and reproductive care firm Kindbody scored a whopping $100 million from life sciences funding agency Perceptive Advisors, bringing its whole increase to $290 million and its valuation to $1.8 billion. 

WHAT ITS FOR

Kindbody affords digital and in-person companies, together with contraception care, egg freezing, fertility testing, gynecological care, and digital wellness and training companies. 

The New York-based firm touts itself as being the fertility advantages platform for 112 corporations, with 42 employer shoppers together with Walmart. 

The funding will permit the corporate to open new clinics in underserved markets within the U.S. and improve its care mannequin. The corporate’s founder and chairman, Gina Bartasi, mentioned it should additionally make strategic acquisitions in 2023. 

“With the help of Perceptive Advisors, and our different buyers, Kindbody is positioned to ship on our imaginative and prescient to assist everybody understand their dream of changing into a mother or father by making high-quality fertility care inexpensive and accessible for all,” Bartasi mentioned in an announcement.

MARKET SNAPSHOT

In 2022, the corporate made three acquisitions, first buying Vios Fertility Institute, a community of fertility clinics working in Illinois, Michigan, Missouri, Oregon, Washington and Wisconsin. 

It then bought genomics firm Phosphorus Labs, combining Phosphorus’ workers of geneticists and lab technicians with the fertility startup’s KindLabs division. 

Lastly, Kindbody introduced it acquired Chicago-based surrogacy company Alternative Reproductive Resources, noting ARR’s staff would work within the firm’s KindEOS division, which focuses on egg and embryo donation. 

Previous to its acquisitions, the corporate introduced the launch of at-home fertility tests for women and men, which measure hormones related to reproductive operate and well being and could possibly be paired with in-person or digital appointments with a Kindbody doctor to debate the outcomes.